MuhammadRehmanMD

PubMed

• 7 citations
  Decoding Attempted Hand Movements in Stroke Patients Using Surface Electromyography
  Mads Jochumsen, Imran Khan Niazi, Muhammad Zia ur Rehman, Imran Amjad, Muhammad Shafique, Syed Omer Gilani, Asim Waris> ;Sensors. 2020 Nov 26
• 3 citations
  A Multiday Evaluation of Real-Time Intramuscular EMG Usability with ANN.
  Asim Waris, Muhammad Zia ur Rehman, Imran Khan Niazi, Mads Jochumsen, Kevin Englehart, Winnie Jensen, Heidi Haavik, Ernest Nlandu Kamavuako> ;Sensors. 2020 Jun 15
• 5 citations
  A comparative study of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgro...
  Hideto Kameda, Eishi Uechi, Tatsuya Atsumi, Carlos Abud-Mendoza, Kazumasa Kamei, Tsugumi Matsumoto, Dario Ponce de Leon, Muhammad I. Rehman, Min Zhang, Sebastião Cezar...> ;International Journal of Rheumatic Diseases. 2020 May 31
• 10 citations
  Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Refer...
  Stanley Cohen, Sebastião Cezar Radominski, Hideto Kameda, Alan Kivitz, Michael L. Tee, Carol Cronenberger, Min Zhang, Sarah Hackley, Muhammad I. Rehman, Oliver von Ric...> ;Biodrugs. 2020 Apr 1
• 4 citations
  Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis
  Rameshraja Palaparthy, Muhammad I. Rehman, Oliver von Richter, D. Yin> ;Expert Opinion on Biological Therapy. 2019 Jul 8
• 10 citations
  The ‘totality-of-the-evidence’ approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the referen...
  Joseph E. McClellan, Hugh D. Conlon, Michael W. Bolt, Vatche Kalfayan, Rameshraja Palaparthy, Muhammad I. Rehman, Carol F. Kirchhoff> ;Therapeutic Advances in Gastroenterology. 2019 Jun 13
• 17 citations
  Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from ...
  Rieke Alten, Bogdan Batko, Tomas Hala, Hideto Kameda, Sebastião Cezar Radominski, Vira Tseluyko, Goran Babic, Carol Cronenberger, Sarah Hackley, Muhammad I. Rehman, Ol...> ;RMD Open. 2019 Mar 1
• 57 citations
  Multiday EMG-Based Classification of Hand Motions with Deep Learning Techniques
  Muhammad Zia ur Rehman, Asim Waris, Syed Omer Gilani, Mads Jochumsen, Imran Khan Niazi, Mohsin Jamil, Dario Farina, Ernest Nlandu Kamavuako> ;Sensors. 2018 Aug 1
• 45 citations
  A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheum...
  Stanley Cohen, Rieke Alten, Hideto Kameda, Tomas Hala, Sebastião Cezar Radominski, Muhammad I. Rehman, Ramesh Palaparthy, Karl Schumacher, Susanne Schmitt, Steven Y. H...> ;Arthritis Research & Therapy. 2018 Jul 27
• Performance of Combined Surface and Intramuscular EMG for Classification of Hand Movements
  Muhammad Zia ur Rehman, Syed Omer Gillani, Asim Waris, Mads Jochumsen, Imran Khan Niazi, Ernest Nlandu Kamavuako> ;Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2018 Oct 26
• 17 citations
  A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01).
  Ramesh Palaparthy, Chandrasekhar Udata, Steven Y. Hua, D. Yin, Chun-Hua Cai, S. Salts, Muhammad I. Rehman, Joseph E. McClellan, Xu Meng> ;Expert Review of Clinical Immunology. 2018 Mar 12
• 42 citations
  A novel approach to CAD system for the detection of lung nodules in CT images
  Muzzamil Javaid, Moazzam Javid, Muhammad Zia ur Rehman, Syed Irtiza Ali Shah> ;Computer Methods and Programs in Biomedicine. 2016 Oct 1
• Join now to see all